chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My wife tested positive for COVID today (Tuesday, 25Jan2022). The only symptom present at the time of this report being submitted is a ''soar throat''.; My wife tested positive for COVID today (Tuesday, 25Jan2022). The only symptom present at the time of this report being submitted is a ''soar throat''.; first dose and second dose were Moderna. 3 dose was Pfizer; first dose and second dose were Moderna. 3 dose was Pfizer; booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 40-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 12Nov2021 (Lot number: FH8030) at the age of 39 years as dose 3 (booster), single for covid-19 immunization. The patient had no relevant medical history. The patient took concomitant medications. Past drug history included: Aspirin, reaction(s): "known allergies: Aspirin". Vaccination history included: Moderna (Dose Number: 2, Batch/Lot No: 039B12A, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 24Apr2021, when the patient was 39 years old, for Covid-19 Immunization; Moderna (Dose Number: 1, Batch/Lot No: 031A21A, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 27Mar2021, when the patient was 39 years old, for Covid-19 Immunization. The following information was reported: OFF LABEL USE (medically significant), INTERCHANGE OF VACCINE PRODUCTS (medically significant) all with onset 12Nov2021, outcome "unknown" and all described as "first dose and second dose were Moderna. 3 dose was Pfizer"; IMMUNISATION (medically significant) with onset 12Nov2021, outcome "unknown", described as "booster"; COVID-19 (medically significant) with onset 25Jan2022, outcome "recovering", DRUG INEFFECTIVE (medically significant) with onset 25Jan2022, outcome "unknown" and all described as "My wife tested positive for COVID today (Tuesday, 25Jan2022). The only symptom present at the time of this report being submitted is a ''soar throat''.". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (25Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of covid-19. Clinical course: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications received within 2 weeks of vaccination. The patient tested positive for COVID on Tuesday, 25Jan2022. The only symptom present at the time of this report being submitted was a sore throat. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Information has been received from an office manager concerning an approximately 28 weeks (reported as "4 months old") female patient who on an unspecified date was vaccinated with the second dose of ROTATEQ. Two days later, the patient developed an adverse event. On 23-JUL-2011, she was admitted to the hospital (name of hospital not specified) and diagnosed with having the rotavirus, since then the child had been discharged (date of discharge not specified) and had an appointment with the physician for follow up on 25-JUL-2011. At the time of the report, the patient's outcome was recovering. "Having the rotavirus" and "adverse event" were considered to be other important medical events by reporter. Additional information has been requested.
Swelling of throat and mouth. Sore throat. Vomiting. Headache.
scab at the injection site/ scab just fell off after 6 months; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SCAB (scab at the injection site/ scab just fell off after 6 months) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SCAB (scab at the injection site/ scab just fell off after 6 months). At the time of the report, VACCINATION SITE SCAB (scab at the injection site/ scab just fell off after 6 months) had resolved.            No concomitant medication was reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Nov-2021: Follow-up received contains: updated reporter information.
Approximately about 1 hour the event, I started to feel nauseas, headaches turned into a migraine headache. I also got chills and vomited. I felt fine the next morning and my symptoms resolved.
Fever- Started 2 hours after 2nd shot Aches- Started immediately Tiredness- Immediately  Sore arm- Immediately
Received DTaP(Glaxo), MMRV(Merck), IPV(Sanofi), Hep A(Merck) at 1015 AM. She was fine after administration and went home. She complained of abdominal pain then had a brief 45-60 sec tonic clonic seizure with loss of consciousness approximately 1 hour later. She was post ictal per mother. She was not febrile. When I examined Patient in clinic at 1145 shortly after seizure, she was had a normal affect and neurological exam.
This initial spontaneous report was received on 04-JAN-2018 from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. On or about 03-MAR-2008, at a physician's office, the patient was inoculated (by an unspecified healthcare professional) with ZOSTAVAX as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, site of administration, lot # and expiration date were not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster.  On or about 06-OCT-2011, the male was treated (by an unspecified healthcare professional) at the eye specialist facility, for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles on the face. On or about 15-DEC-2011, the patient sought subsequent treatment from the eye specialist facility for ongoing and worsening symptoms of Herpes zoster with face and eye interference. The patient has been prescribed acyclovir, gabapentin for management of his painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was not resolved.  The lawyer felt the events were related to ZOSTAVAX. Upon internal review, the event of ongoing and worsening symptoms of herpes zoster with face and eye interference was determined to be medically significant. Additional information has been requested.
Vaccine diluted with single use sterile 0.9% sodium chloride that is to be used for irrigation rather than injection.
Client presented to vaccine clinic for 1st dose of Moderna (monovalent-primary series). Moderna bivalent given instead of Moderna monovalent. Per CDC, dose repeated with Moderna monovalent.
Local injection site reaction; This case was reported by a consumer via call center representative and described the occurrence of injection site reaction in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was resolved with sequelae.   It was unknown if the reporter considered the injection site reaction to be related to Shingrix.  Additional details were received as follows: The case was reported by patient's wife. The age at vaccination was not reported. The reporter stated that the patient experienced local injection site reaction after vaccination. This case has been linked with the cases US2019AMR231309 and US2019230529, reported by the same reporter.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. Concurrent conditions, medical history and allergies were not reported. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of oral, ROTATEQ lot # K010221, K011663, K016313 and lot # reported as K015816 (expiration dates, dose, route and site of administration were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the medical assistant on 02-JUL-2015 concerning a patient of an unknown age and gender who on 06-MAY-2015 was vaccinated with a dose of oral, ROTATEQ (lot # K015816) (dose and route not reported) that was 63 hours temperature excursion. This is one of several reports received from the same source. Additional information is not expected as all correspondence was received.
Chest Pain. Worsened with full breadth or being bent over.  Peaked in intensity July 27-29th but lingered until Aug 6th
24 hours after vaccine: fever, neck pain, arm pain, body aches, chills, exhaustion- felt this way for 48 hours.
This is a spontaneous report from a contactable nurse. This nurse reported similar events for six patients. This is the third of six reports. A male patient (age and race unknown) received a dose of PREVNAR13 on an unknown date. Relevant medical history and concomitant medications were unknown. On an unknown date, the patient experienced irritability and inconsolable crying. Relevant laboratory data were unknown. Therapeutic measures taken in response to event were unknown. At time of reporting,  the patient had recovered on an unknown date after experiencing the events for couple of weeks. Follow-up (06JUN2011): This is a follow-up spontaneous report from the same contactable nurse. The nurse reported that she had only reported on one patient, but had receive five letters, for the same patient, in error. As a result, five cases were erroneously created regarding the same patient. There is actually only one patient and one valid case (201111773).
Information has been received from a physician concerning her healthy 25 month old niece who on approximately 10/14/2004 was vaccinated with a dose of varicella virus vaccine live.  On 11/04/2004, 3 weeks after vaccination, the patient developed a vesicular rash.  The lesions were on her face, chest, and buttocks.  No treatment was prescribed.  The patient's vesicular rash persisted.  A product quality complaint was not involved.  Additional information has been requested.
Hallucinating; Occasional rapid heart beat; Hadache; A spontaneous report was received from a caregiver concerning reporter's mother a 97-year-old, female patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced hallucinating/ hallucination, occasional rapid heartbeat/ heart rate irregular and headache.   The patient's current conditions included chronic urinary tract infection. Products known to have been used by the patient, within two weeks prior to the event, included antibiotics for chronic urinary tract infection.   On 26-Feb-2021, prior to the onset of the symptoms, the patient received their unspecified dose of two planned doses of mRNA-1273 (Batch number not provided) via an unknown route and site for prophylaxis of COVID-19 infection.  On 27-Feb-2021 the patient had headache for 2 days, was hallucinating and had occasional rapid heartbeat.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.  The Outcome of the events, hallucinating,  occasional Rapid Heartbeat, and headache was unknown.  Company Comment: The reported events, hallucinations, heart rate irregular, and headache,  were considered possibly related to mRNA-1273.; Reporter's Comments: Based on the current available information which includes a temporal association between the use of the product and the start date of the reported event and excluding any other etiology, a causal relationship with the event cannot be excluded. Headache is consistent with the vaccine profile
Patient identified as high risk in registration. Patient received vaccination and immediately began to develop hives and itching on neck and a mild rash on her face. She took 50mg benadryl of her own. She stated she has had anaphylactic reactions to the flu vaccine, however denied shortness of breath at the time. Staff immediately called EMS. EMS arrived at 1133. Patient was evaluated by EMS. Hives had spread to her arms. She stated she was feeling better. EMS told her she could come to the hospital or not. Patient declined hospital transfer. Patient left stable and feeling well. She stated she would call 991 if anything else occurred.
Have had evolving symptoms over the past two months since vaccine.  Starting with Tinnitus, fullness in ear, eye issues (feels off, potential lag).  About a month in, pressure in nose, which goes through to tops of teeth came on.  Soon after, started feeling other neurological symptoms, including pain in hands, wrist, forearms and right foot.  Symptoms seem to come in waves.
I started observing that my daughter, patient, started to have shortness of breath on Dec. 15th 2021. This gradually increased and she would have the shortness of breath episodes like 6-7 times a day, and more recently on 13th Feb. 2022 night, before sleeping she had trouble falling asleep, she had pain in her chest and the same thing continued the next day. On Feb.15th, we took her to our local Family Clinic and Dr. ordered an ECG, though the ECG report was normal, the doctor did not rule out PERICARDITIS. And patient has started taking Motrin 10 ml 3 times a day on the doctor's advise.
Hives all over torso especially middle of body.  Large bumps and very red and itchy by the time I got home...(1 hour later?) Took Benadryl dose and by 8pm hives on backs of knees and between thighs...blotchy itchy and red. Woke at 430am to same symptoms but less redness and bumps on torso
I thought I am having a stroke; My left leg started going numb and it was all my leg from my waist all the way down; leg mostly of the time it starts going numb. And it hurts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), on 16Oct2021 as dose 4 (booster), single (Lot number: 30155BA) at the age of 70 years, in arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed; unknown manufacturer), for COVID-19 Immunization; Bnt162b2 (Covid-19 First Booster vaccine, got my booster (clarified as first Covid-19 Booster vaccine) on May the 21st or 22 and I don't know if you need this FJ4989."), for COVID-19 Immunization. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant) with onset Oct2021, outcome "not recovered", described as "I thought I am having a stroke"; HYPOAESTHESIA (non-serious) with onset Oct2021, outcome "not recovered", described as "My left leg started going numb and it was all my leg from my waist all the way down"; PAIN IN EXTREMITY (non-serious) with onset Oct2021, outcome "not recovered", described as "leg mostly of the time it starts going numb. And it hurts". The events "i thought i am having a stroke", "my left leg started going numb and it was all my leg from my waist all the way down" and "leg mostly of the time it starts going numb. and it hurts" required physician office visit. The patient underwent the following laboratory tests and procedures: Blood test: everything is fine. Therapeutic measures were not taken as a result of cerebrovascular accident, hypoaesthesia, pain in extremity.  Additional information: "Yes, I did what I got was my about two to three weeks afterwards my leg, my left leg started going numb and it was all my leg from my waist all the way down and I thought I am having a stroke so I went to my doctor, I am very healthy I get all my vaccines but I didn't get this from the Covid Pfizer vaccine it was from the Booster and so then because I do some exercise during the week you know I applied alcohol and rubbed it  and it finally diminished about a month afterwards well, now it and I went to see my doctor again and now once like once a month or twice a month it comes back and it started numbing and I went to see my doctor again. I have to make sure I walk around a lot and it's not like it's frozen or like you know I have tingling, it goes numb and I start shaking it takes me about half an hour to make sure that I get it going to where you know and it's painful I started crying and eventually I get it to where it goes away but I could say I reported to my doctor I reported to my cardiologist which I always go to my appointment. I even reported to my dentist I go back to see my doctor again at the end of this month because he wants to check on it. I didn't have any other vaccine administered, none."
An 86-year-old patient was administered a Moderna 0.5 vaccine in the left lower limb. Once administered the area was inflamed, it was not hot to the touch.
Patient under the age of 18 received a Moderna booster instead of a Comirnaty Booster.
This spontaneous report was received from a certified medical assistant (CMA) refers to a currently 71 year old female patient. Current conditions included hypertension and Irritable Syndrome (IBS). Drug reactions/allergies included allergy to codeine and IVP dye. On an unknown age in 2007 the patient was vaccinated with a dose of PNEUMOVAX23 (lot # not reported) intramuscularly. No concomitant medications were reported. On an unknown date after receiving PNEUMOVAX23 the patient developed rash near the site of injection. The patient recovered on an unknown date. It was unspecified whether patient sought medical attention. No further information is available.
Got a horrible debilitating  headache within just a few hours after getting the vaccine and have had that headache every single day since then. I have seen my primary care numerous times,  a neurologist, and an ent. I have tried all kinds of prescription medications with no real results. I have had a headache everyday for 8 months.  I also experienced rapid heart rate for months after the vaccine. I was referred to a cardiologist who prescribed medication after wearing a monitor for 2 weeks. The rapid heart rate has improved since and trying it without medication. So far it?s ok.
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 17-AUG-2015, the patient was vaccinated with improperly stored VARIVAX (Merck), lot# L006383, expiration date: 25-FEB-2017 (dose and route unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Severe shortage of Breath Chest pains Heart palpitations, seemed like heart was beating very rapidly. Above lasted for about 5 days and then symptoms ceased and now seem fully normal My Dr. did not recommend any additional test or treatment
pt recv vax 5OCT98 & 16OCT98 hands & feet turned red,  legs turning red, lt leg hives & splotching 7OCT98;all joints painful, difficult to walk, no strength in joints, h/a;immune rxn;
no adverse event; multiple patients were vaccinated with an improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 10-JUN-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 ml, orally, LOT# R034700, expiry date 16-JUN-2020 for prophylaxis. The vaccine was exposed to a temperature of 34.2 F for 4 hours and 54 minutes. This call was made because of a digital data logger. There were no previous temperature excursions. No adverse effects were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1907USA000862: US-009507513-1907USA000883: US-009507513-1907USA000884: US-009507513-1907USA000885: US-009507513-1907USA000886: US-009507513-1907USA000887: US-009507513-1907USA000888: US-009507513-1907USA000889: US-009507513-1907USA000890: US-009507513-1907USA000891: US-009507513-1907USA000892: US-009507513-1907USA000893: US-009507513-1907USA000894: US-009507513-1907USA000895: US-009507513-1907USA000896: US-009507513-1907USA000897: US-009507513-1907USA000901: US-009507513-1907USA000899: US-009507513-1907USA000898: US-009507513-1907USA000900: US-009507513-1907USA000902: US-009507513-1907USA000903: US-009507513-1907USA000904: US-009507513-1907USA000905: US-009507513-1907USA000906: US-009507513-1907USA000907: US-009507513-1907USA000908: US-009507513-1907USA000909: US-009507513-1907USA000910: US-009507513-1907USA000911: US-009507513-1907USA000912: US-009507513-1907USA000913: US-009507513-1907USA000914: US-009507513-1907USA000915: US-009507513-1907USA000916: US-009507513-1907USA000917: US-009507513-1907USA000918: US-009507513-1907USA000919: US-009507513-1907USA000920: US-009507513-1907USA000921: US-009507513-1907USA000922: US-009507513-1907USA000923: US-009507513-1907USA000924: US-009507513-1907USA000925: US-009507513-1907USA000926: US-009507513-1907USA000927: US-009507513-1907USA000928: US-009507513-1907USA000929: US-009507513-1907USA000930: US-009507513-1907USA000931: US-009507513-1907USA000932: US-009507513-1907USA000933: US-009507513-1907USA000934: US-009507513-1907USA000935: US-009507513-1907USA000936: US-009507513-1907USA000937: US-009507513-1907USA000938: US-009507513-1906USA011674:
Narrative:  Patient received the J&J covid vaccine on 4/2/21. He then got the Moderna vaccine 1/15/22. He presented to the ER with a stroke on 2/6/22. He has a history of prior CVAs in 2010 and 2015 and has been on rivaroxaban 20mg po daily since 1/10/20 (previously on warfarin before that since 3/2015).
malaise; loss of appetite; was down for a day; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (malaise), DECREASED APPETITE (loss of appetite), ASTHENIA (was down for a day) and CHILLS (chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced MALAISE (malaise), DECREASED APPETITE (loss of appetite), ASTHENIA (was down for a day) and CHILLS (chills). On 15-Feb-2021, MALAISE (malaise), DECREASED APPETITE (loss of appetite), ASTHENIA (was down for a day) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.